1. Home
  2. VNET vs HAE Comparison

VNET vs HAE Comparison

Compare VNET & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VNET Group Inc.

VNET

VNET Group Inc.

HOLD

Current Price

$9.08

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$54.12

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNET
HAE
Founded
1999
1971
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
VNET
HAE
Price
$9.08
$54.12
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$12.60
$84.13
AVG Volume (30 Days)
4.9M
685.1K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.54
EPS
N/A
2.46
Revenue
N/A
$910,373,000.00
Revenue This Year
$20.06
N/A
Revenue Next Year
$21.04
$5.23
P/E Ratio
N/A
$21.24
Revenue Growth
N/A
N/A
52 Week Low
$5.15
$47.32
52 Week High
$14.48
$87.32

Technical Indicators

Market Signals
Indicator
VNET
HAE
Relative Strength Index (RSI) 52.98 39.60
Support Level $8.30 $48.91
Resistance Level $9.51 $56.64
Average True Range (ATR) 0.41 2.93
MACD 0.09 -0.64
Stochastic Oscillator 66.12 25.00

Price Performance

Historical Comparison
VNET
HAE

About VNET VNET Group Inc.

VNET started as AsiaCloud in 1999 and moved into the data center business, opening its first self-developed data center in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of September 2025, it had 52,288 retail cabinets, with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 783 MW of wholesale capacity in service, with a further 306 MW under construction and a further 705 MW held for future development.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: